Search results (76)
« Back to PublicationsCost-Effectiveness of Community-Based Repurposed Therapies for COVID-19 in the PRINCIPLE Trial
Journal article
PNG ME. et al, (2026), Cost Effectiveness and Resource Allocation
Cost-effectiveness of N-terminal pro-B-type natriuretic peptide thresholds for echocardiography referral in primary care heart failure management.
Journal article
Png ME. et al, (2026), Heart
Economic Evaluation of Oral Nirmatrelvir-Ritonavir for COVID-19 in Higher Risk Outpatients
Journal article
Png ME. et al, (2026), JAMA Network Open, 9
Economic Evaluation of Oral Nirmatrelvir-Ritonavir for COVID-19 in Higher Risk Outpatients
Journal article
Png ME. et al, (2026), JAMA Network Open, 9, e2612381 - e2612381
Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients
Journal article
Butler CC. et al, (2026), New England Journal of Medicine, 394, 1583 - 1594
Cost-effectiveness of osteoporotic fracture risk assessment in people with intellectual disabilities: a UK NHS modelling study
Journal article
Png ME. et al, (2026), BMJ Open, 16
The utilisation and cost of social care after hip fracture: a prospective observational cohort study
Journal article
Goh EL. et al, (2026), Age and Ageing, 55
Cost-effectiveness of N-terminal pro-B-type natriuretic peptide thresholds for echocardiography referral in primary care heart failure management
Journal article
Png ME. et al, (2026), Heart
Association between surgeon experience, level of supervision, and outcomes after hip fracture
Journal article
Goh EL. et al, (2026), Bone and Joint Open, 7, 744 - 752
Clinical outcomes following treatment of extracapsular hip fractures with long compared with short cephalomedullary nails
Journal article
Goh EL. et al, (2025), Bone Joint Journal, 107-B, 1325 - 1332
The impact of complications on quality of life and mortality after hip fracture
Journal article
Goh EL. et al, (2025), Bone and Joint Journal, 107-B, 1118 - 1124
Risk factors associated with the development of complications after a hip fracture
Journal article
Goh EL. et al, (2025), Bone and Joint Journal, 107B, 950 - 956
A Viroimmunologic Model to Characterize the Antiviral Effect of Molnupiravir in Outpatients Infected With SARS-CoV-2: Implication for Treatment Duration
Journal article
Nguyen BT. et al, (2025), Journal of Infectious Diseases, 231, e1080 - e1090
Cost-effectiveness of routine COVID-19 adult vaccination programmes in England
Journal article
Keeling MJ. et al, (2025), Vaccine, 53
Cost-Effectiveness of Home-Based COVID-19 Treatments: Findings From the PRINCIPLE Trial
Conference paper
PNG M. et al, (2025)